Related Experiment Video
Updated: Aug 9, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Chronic Kidney Disease and COVID-19 Infection: A Case-Control Study
Firouzeh Moeinzadeh1, Mojgan Mortazavi1, Shahrzad Shahidi1
1Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
Chronic kidney disease (CKD) patients did not show a higher susceptibility to COVID-19 infection compared to healthy individuals. Symptoms like fever and cough were more prevalent in the healthy group, not CKD patients.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- Understanding risk factors for COVID-19 infection is crucial for disease management.
- While kidney disease is common in COVID-19 patients, data on chronic kidney disease (CKD) and COVID-19 susceptibility are limited.
- This study investigates the association between CKD and COVID-19 infection risk.
Purpose of the Study:
- To examine the association between chronic kidney disease (CKD) and susceptibility to COVID-19 infection.
- To compare the incidence of COVID-19 symptoms and infection rates between CKD patients and healthy controls.
Main Methods:
- A cross-sectional survey was conducted on 962 Iranian adults (403 with CKD, 559 healthy controls).
- Participants completed a questionnaire on COVID-19 clinical symptoms, epidemiology, and hospitalization data.
- Statistical analysis compared infection rates and symptom prevalence between CKD patients and controls across different CKD stages.
Main Results:
- Healthy controls reported more symptoms including fever, cough, sore throat, headache, anosmia, dyspnea, and abdominal pain compared to CKD patients (P < 0.05).
- Myalgia was marginally higher in healthy individuals (P = 0.057).
- No significant difference in COVID-19 infection rates was observed between CKD patients and healthy controls across various CKD stages (P = 0.956).
Conclusions:
- Clinical presentations of COVID-19 were more common in healthy individuals than in the CKD group.
- Susceptibility to COVID-19 infection did not significantly differ between CKD patients and healthy individuals, even in early stages of CKD.
Background:
To organize efforts to manage the coronavirus disease 2019 (COVID-19), it is necessary to understand which groups are at higher risk of infection. Kidney disease seems to be substantial in COVID-19 patients, but there are limited data on COVID-19 incidence and fatality among chronic kidney disease (CKD) patients. In this study, we intend to examine the association between CKD and susceptibility to COVID-19 infection.
Materials And Methods:
Participants were selected from those recruited in a population-based cross-sectional survey of CKD prevalence and associated risk factors in Iranian people 18 years and older. A three-part questionnaire was used for COVID-19 infection clinical symptoms and epidemiologic and hospitalization data.
Results:
A total of 962 individuals including 403 CKD patients and 559 healthy controls were recruited in this study. Healthy controls were suffering more from common cold signs, cough, fever, sore throat, headache, anosmia, dyspnea, and abdominal pain (all P < 0.05). Furthermore, the number of healthy individuals with myalgia was marginally higher compared to the CKD patients (P = 0.057). Data regarding the number of CKD patients with/without COVID-19 infection throughout different CKD stages revealed that there was no significant difference between the two groups in terms of COVID-19 infection in different stages of CKD (P = 0.956).
Conclusion:
We found that some of the clinical presentations of COVID-19 including common cold symptoms, cough, fever, sore throat, headache, anosmia, dyspnea, and abdominal pain were higher among healthy individuals compared to the CKD group. On the other hand, the susceptibility to COVID-19 infection was not significantly different in various early stages of CKD.
More Related Videos
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction

